• LAST PRICE
    39.5100
  • TODAY'S CHANGE (%)
    Trending Up0.1200 (0.3046%)
  • Bid / Lots
    25.1800/ 1
  • Ask / Lots
    40.2000/ 1
  • Open / Previous Close
    39.7200 / 39.3900
  • Day Range
    Low 38.8800
    High 40.1500
  • 52 Week Range
    Low 33.0450
    High 76.9800
  • Volume
    340,912
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 39.35
TimeVolumeIMCR
09:32 ET1738138.9
09:34 ET50039.295
09:38 ET16739.2
09:39 ET70039.43
09:41 ET268439.59
09:43 ET180039.63
09:45 ET99539.68
09:48 ET240039.705
09:50 ET50039.75
09:52 ET20039.785
09:54 ET40039.645
09:57 ET80039.815
09:59 ET50039.8
10:01 ET10039.92
10:03 ET75439.775
10:06 ET40039.82
10:10 ET60039.78
10:12 ET240039.91
10:14 ET200039.87
10:15 ET90039.85
10:17 ET386239.85
10:19 ET158639.85
10:21 ET70039.92
10:24 ET20039.85
10:26 ET100039.8
10:28 ET66039.85
10:30 ET40039.825
10:32 ET80039.85
10:33 ET59839.85
10:35 ET103739.85
10:37 ET124639.91
10:39 ET550740.065
10:42 ET181140.06
10:44 ET168339.88
10:46 ET20039.94
10:48 ET30039.86
10:51 ET90039.69
10:53 ET10039.61
10:55 ET30039.525
10:57 ET40039.515
11:02 ET20039.48
11:04 ET103139.425
11:06 ET20039.31
11:11 ET140039.35
11:13 ET20039.34
11:15 ET110039.34
11:18 ET30039.39
11:20 ET308939.435
11:22 ET427439.34
11:24 ET20039.33
11:26 ET20039.4
11:29 ET10039.37
11:31 ET250139.28
11:33 ET50039.1
11:36 ET50439.145
11:40 ET110039.08
11:42 ET20039.095
11:45 ET20039.06
11:47 ET30039.11
11:49 ET100039.09
11:54 ET90039.16
12:00 ET175339.09
12:03 ET319939.1
12:05 ET104139.07
12:07 ET40039.16
12:09 ET50039.13
12:21 ET61839.08
12:23 ET20039.1
12:25 ET317739.23
12:27 ET185039.26
12:30 ET748639.06
12:32 ET20039.105
12:39 ET10039.06
12:41 ET10039.055
12:43 ET40039.1
12:50 ET30039.09
12:52 ET180039.09
12:56 ET40039.08
12:59 ET10039.09
01:03 ET30039.035
01:06 ET30039.065
01:14 ET439939.13
01:17 ET40039.17
01:19 ET151539.17
01:21 ET370039.1233
01:24 ET131839.0144
01:28 ET200039
01:30 ET20039.06
01:33 ET50039.13
01:35 ET10839.1378
01:37 ET30039.11
01:39 ET20039.04
01:42 ET10039.04
01:46 ET93539.06
01:50 ET24239.06
01:55 ET71839.16
02:00 ET60039.09
02:04 ET10039.055
02:06 ET152539.14
02:08 ET20039.14
02:11 ET10039.205
02:15 ET10039.2
02:33 ET10039.2
02:36 ET122639.31
02:38 ET61439.34
02:40 ET20039.365
02:42 ET50039.32
02:44 ET20039.24
02:45 ET20039.26
02:47 ET10039.24
02:49 ET10039.2
02:51 ET85739.4
02:54 ET494339.42
02:56 ET100039.37
02:58 ET10039.375
03:00 ET347239.58
03:02 ET60039.66
03:03 ET70039.58
03:05 ET7152139.5
03:07 ET40039.53
03:09 ET20039.52
03:12 ET214739.75
03:14 ET40639.66
03:16 ET30039.73
03:18 ET39639.705
03:20 ET40039.78
03:21 ET10039.825
03:23 ET70039.795
03:25 ET40039.83
03:27 ET290339.7348
03:30 ET20039.77
03:32 ET110039.645
03:34 ET60039.65
03:36 ET130839.7
03:38 ET10039.685
03:39 ET10039.62
03:41 ET20039.56
03:43 ET233939.51
03:45 ET104039.54
03:50 ET120039.55
03:52 ET110439.4
03:54 ET229239.32
03:56 ET89739.34
03:57 ET424639.425
03:59 ET2192639.51
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesIMCR
Immunocore Holdings PLC
2.0B
-32.9x
---
United StatesLGND
Ligand Pharmaceuticals Inc
1.8B
19.0x
-12.71%
United StatesINVA
Innoviva Inc
1.0B
7.5x
-8.76%
United StatesEOLS
Evolus Inc
736.9M
-11.3x
---
United StatesAVDL
Avadel Pharmaceuticals PLC
1.6B
-8.9x
---
United StatesHROW
Harrow Inc
835.4M
-26.0x
---
As of 2024-07-13

Company Information

Immunocore Holdings plc is a United Kingdom-based commercial-stage biotechnology company. The Company is engaged in the development of TCR bispecific immunotherapies, ImmTAX, which immunes mobilizing monoclonal TCRs Against X disease, designed to treat a range of diseases, including cancer, autoimmune and infectious disease. The Company has a clinical-stage pipeline of wholly owned and partnered programs across three different therapeutic areas: oncology, infectious diseases, and autoimmune and inflammation diseases. Its lead product, KIMMTRAK, is a TCR therapeutic for the treatment of patients with unresectable or metastatic uveal melanoma (mUM), in the United States, European Union, Canada, Australia and the United Kingdom. Its pipeline products include IMC-F106C, IMC-F115C, IMC-F119C, IMC-F117C, IMC-F113V, IMC-I109V, IMC-SII8AI, among others. Its clinical programs are being conducted with patients with a range of cancers including melanoma, lung, gastric and others.

Contact Information

Headquarters
90 Park Drive, Milton Park, AbingdonABINGDON, United Kingdom OX14 4RY
Phone
123-543-8600
Fax
---

Executives

Independent Chairman of the Board
John Bell
Chief Executive Officer, Director
Bahija Jallal
Chief Financial Officer, Head of Strategy
Brian Di Donato
Chief Human Resource Officer
Tina St Leger
Head of Research and Development
David Berman

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$2.0B
Revenue (TTM)
$265.8M
Shares Outstanding
50.0M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.77
EPS
$-1.20
Book Value
$7.42
P/E Ratio
-32.9x
Price/Sales (TTM)
7.4
Price/Cash Flow (TTM)
---
Operating Margin
-24.46%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.